{"schema_version":"secwatch.filing_event.v1","accession":"0000097745-25-000093","form_type":"8-K","ticker":"TMO","cik":"0000097745","company_name":"THERMO FISHER SCIENTIFIC INC.","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.788004+00:00","generated_at":"2026-05-18T04:01:03.104815+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Thermo Fisher Q2: rev +3% to $10.85B, GAAP EPS $4.28 (+6%), adj EPS $5.36","bullets":["Q2 revenue $10.85B (+3% YoY; organic 2%); GAAP diluted EPS $4.28, up 6% from $4.04.","Adjusted EPS $5.36 (vs $5.37); GAAP op margin 16.9% (down 40bps); adj op margin 21.9% (down 40bps).","2025 annual guidance to be updated during today's earnings call.","New product launches: Orbitrap Astral Zoom MS, Krios 5 Cryo-TEM, DynaDrive bioreactor bench scale.","Post-quarter: expanded Sanofi partnership, acquiring Ridgefield, NJ sterile fill-finish site."],"urls":{"canonical":"https://secwatch.observer/filing/0000097745-25-000093","json":"https://secwatch.observer/filing/0000097745-25-000093.json","markdown":"https://secwatch.observer/filing/0000097745-25-000093.md","text":"https://secwatch.observer/filing/0000097745-25-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/97745/000009774525000093/0000097745-25-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/97745/000009774525000093/tmo-20250723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:01:03.104815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}